GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 101 filers reported holding GRITSTONE ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $95,000 | -99.1% | 8,761 | -99.7% | 0.00% | -100.0% |
| Q4 2020 | $10,116,000 | +48.7% | 2,567,445 | 0.0% | 0.04% | +38.5% |
| Q3 2020 | $6,804,000 | -60.1% | 2,567,445 | 0.0% | 0.03% | -63.9% |
| Q2 2020 | $17,048,000 | +14.1% | 2,567,445 | 0.0% | 0.07% | -33.3% |
| Q1 2020 | $14,943,000 | -35.1% | 2,567,445 | 0.0% | 0.11% | -28.0% |
| Q4 2019 | $23,030,000 | +3.8% | 2,567,445 | 0.0% | 0.15% | +17.2% |
| Q3 2019 | $22,183,000 | -22.4% | 2,567,445 | 0.0% | 0.13% | -14.1% |
| Q2 2019 | $28,601,000 | -16.2% | 2,567,445 | 0.0% | 0.15% | -10.2% |
| Q1 2019 | $34,147,000 | -13.9% | 2,567,445 | 0.0% | 0.17% | -24.9% |
| Q4 2018 | $39,667,000 | – | 2,567,445 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,561,150 | $6,125,178 | 3.26% |
| Redmile Group, LLC | 8,509,126 | $14,635,697 | 0.70% |
| Avidity Partners Management LP | 2,733,800 | $4,702,136 | 0.19% |
| Frazier Life Sciences Management, L.P. | 1,430,878 | $2,461,110 | 0.16% |
| Artia Global Partners LP | 95,170 | $163,692 | 0.07% |
| Worth Venture Partners, LLC | 43,772 | $75,288 | 0.04% |
| SkyOak Wealth, LLC | 60,875 | $104,705 | 0.03% |
| Point72 Asset Management, L.P. | 5,924,867 | $10,190,771 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 76,811 | $132,115 | 0.02% |
| Houlihan Financial Resource Group, Ltd. | 20,000 | $38 | 0.02% |